Amdocs Stock Forecast, Price & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DOX stock has decreased by 5.6% and is now trading at $57.99.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Amdocs.

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) released its earnings results on Wednesday, August, 5th. The technology company reported $1.07 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.05 by $0.02. The technology company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.01 billion. Amdocs had a return on equity of 15.30% and a net margin of 11.71%.
View Amdocs' earnings history.

Amdocs declared a quarterly dividend on Wednesday, August 5th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.327 per share on Friday, October 23rd. This represents a $1.31 annualized dividend and a yield of 2.26%. The ex-dividend date of this dividend is Tuesday, September 29th.
View Amdocs' dividend history.

Amdocs updated its fourth quarter earnings guidance on Wednesday, August, 5th. The company provided EPS guidance of $1.16-1.22 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.16. The company issued revenue guidance of $1.015-1.055 billion, compared to the consensus revenue estimate of $1.03 billion.

5 brokerages have issued 1-year price objectives for Amdocs' shares. Their forecasts range from $72.00 to $76.00. On average, they anticipate Amdocs' share price to reach $74.40 in the next year. This suggests a possible upside of 28.3% from the stock's current price.
View analysts' price targets for Amdocs.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Leidos (LDOS), Booz Allen Hamilton (BAH), Gartner (IT), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AT&T (T), Home Depot (HD), Pfizer (PFE), Exxon Mobil (XOM), AbbVie (ABBV), IBM (IBM), NVIDIA (NVDA), Cisco Systems (CSCO), Walt Disney (DIS) and Johnson & Johnson (JNJ).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (11.52%), Nordea Investment Management AB (5.12%), LSV Asset Management (3.80%), AQR Capital Management LLC (1.63%), Robeco Institutional Asset Management B.V. (1.32%) and Bank of America Corp DE (1.29%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Cooke & Bieler LP, AQR Capital Management LLC, FIL Ltd, Goldman Sachs Group Inc., Anchor Capital Advisors LLC, Two Sigma Advisers LP, Nuveen Asset Management LLC, and Charles Schwab Investment Management Inc..

DOX stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, FMR LLC, LSV Asset Management, Wedge Capital Management L L P NC, Alyeska Investment Group L.P., Prudential Financial Inc., CWM LLC, and Principal Financial Group Inc..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $57.99.

Amdocs has a market capitalization of $7.82 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.

The official website for Amdocs is www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]